Clinical Trial Update: Total Neoadjuvant Therapy With Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Ultra Low Rectal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating total neoadjuvant therapy with short-course radiation followed by Envafolimab plus CAPEOX in MSS locally advanced ultra low rectal a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• CAPEOX
• Envafolimab (envafolimab)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN